45 results
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
as Acasti’s Vice President – Program Management since May 2023. Mr. Kumar is an experienced drug development, CMC, and program management expert … committee financial expert”, as defined by applicable regulations of the SEC and meets the financial sophistication requirements of the Nasdaq listing rules
8-K
b9xej9rqcw
11 May 23
Departure of Directors or Certain Officers
4:50pm
8-K
EX-99.1
xk9 utg9tcpu1qnbp
21 Jul 21
Other Events
5:17pm
425
EX-99.1
vyl by6ki4tfo
21 Jul 21
Business combination disclosure
5:15pm
424B3
d6vejy4 ntf0x
15 Jul 21
Prospectus supplement
4:45pm
S-4
tw2 8azrm7hxgk3
1 Jul 21
Registration of securities issued in business combination transactions
12:00am